Regeneron Pharmaceuticals | Marktkapitalisierung



Market Capitalization Veränderung Datum
Alnylam Pharmaceuticals USD 42.52B 7.39B 2025-06
Amgen USD 167.51B 27.54B 2025-03
Astellas Pharma JPY 2.56T 56.74B 2025-06
AstraZeneca GBP 172.15B 43.36B 2025-08
Biogen USD 18.78B 365M 2025-08
BioMarin Pharmaceutical USD 13.56B 1.02B 2025-03
Bristol-Myers Squibb USD 88.92B 5.28B 2025-08
Eli Lilly USD 741.66B 8.79B 2025-03
Gilead Sciences USD 139.68B 24.59B 2025-03
GlaxoSmithKline GBP 57.88B 1.64B 2025-08
Incyte USD 16.74B 3.56B 2025-08
Ionis Pharmaceuticals USD 6.24B 47M 2025-08
J&J USD 366.71B 32.94B 2025-06
Kyowa Hakko Kirin JPY 1.3T 153.75B 2025-06
Merck USD 199.34B 571M 2025-08
Moderna USD 11.65B 691M 2025-08
Neurocrine Biosciences USD 12.76B 320M 2025-08
Novartis CHF 256.18B 64.49B 2025-06
Pfizer USD 143.72B 6.63B 2025-03
Sarepta Therapeutics USD 6.19B 5.59B 2025-03
Ultragenyx Pharmaceutical USD 3.4B 485M 2025-03


Regeneron Pharmaceuticals Marktkapitalisierung - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.